Saboo Sodium Chloro Experiences Revision in Its Stock Evaluation Amid Mixed Financial Signals
Saboo Sodium Chloro has experienced a revision in its score by MarketsMojo, reflecting concerns over its long-term fundamental strength and debt servicing challenges. Despite recent positive financial results, the stock remains in a mildly bullish technical range, indicating mixed market sentiment. It has also been added to MarketsMojo's list.
Saboo Sodium Chloro, a microcap player in the FMCG sector, has recently experienced a revision in its score by MarketsMOJO, reflecting a notable adjustment in its evaluation. This change comes in light of the company's ongoing challenges, particularly its long-term fundamental strength, which has been under scrutiny due to a decline in operating profits over the past five years.Despite these hurdles, Saboo Sodium Chloro has shown resilience in its recent financial performance. For the half-year ending September 2024, the company reported an operating cash flow of Rs 5.18 crore, alongside a significant increase in net sales, which rose by 28.50% to reach Rs 27.37 crore. The profit after tax for this period stood at Rs 2.65 crore, indicating a positive trend in its operational efficiency.
From a technical perspective, the stock is currently positioned within a mildly bullish range, buoyed by favorable indicators such as MACD and Bollinger Bands. The company's return on capital employed (ROCE) is recorded at 5.9, and it is trading at a valuation that suggests a discount compared to its historical metrics, as indicated by a 1.9 enterprise value to capital employed ratio.
In a strategic move, Saboo Sodium Chloro has also been added to MarketsMOJO's list, which may provide further insights into its potential for recovery and growth. Over the past year, the stock has generated a commendable return of 29.03%, with profits soaring by an impressive 209.3%. As the market continues to evaluate the company's trajectory, stakeholders will be keenly watching for any further developments in its financial health and market positioning.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
